Herceptin

Latest stories

1h
PharmaceuticalOnline
Could 96 Percent FDA Drug Approval Rate Harm Biosimilar MarketLast week, Matthew Harper of Forbes published an eye-opening article providing
Could 96 Percent FDA Drug Approval Rate Harm Biosimilar Market
PharmaceuticalOnline / Posted an hour ago
Last week, Matthew Harper of Forbes published an eye-opening article providing a closer look at FDA approvals in recent years, coming to the conclusion that the industry is facing what could be a dangerously high approval rate for new drugs. But how... Read more
1d
PhysOrg
Antibody-making bacteria promise drug developmentEscherichia coli. Credit: Rocky Mountain Laboratories, NIAID, NIH Monoclonal an
Antibody-making bacteria promise drug development
PhysOrg / Posted yesterday
Escherichia coli. Credit: Rocky Mountain Laboratories, NIAID, NIH Monoclonal antibodies, proteins that bind to and destroy foreign invaders in our bodies, routinely are used as therapeutic agents to fight a wide range of maladies including breast... Read more
4d
Business Wire
Global & USA BioSimilar Market Analysis to 2021The highly awaited US Biosimilar market will be initiated in September as Sando
Global & USA BioSimilar Market Analysis to 2021
Business Wire / Posted 4 days ago
The highly awaited US Biosimilar market will be initiated in September as Sandoz launches its highly awaited filigrastim biologic, Zarxio. How will the global market react? Will biosimilars explode into the biologics market? The author reveals that... Read more
5d
Orlando Sentinel
Doctor explains 'triple negative' breast cancerQ: A good friend of mine in her 50s was just diagnosed with breast cancer. She
Doctor explains 'triple negative' breast cancer
Orlando Sentinel / Posted 5 days ago
Q: A good friend of mine in her 50s was just diagnosed with breast cancer. She told me she is "triple negative" and that this is somehow more serious than usual. Can you tell what this means? A: Triple negative breast cancer refers to testing of the... Read more
6d
Daily Mirror
Grandaughter and gran BOTH diagnosed with aggressive breast cancer in same weekBrave Madison Joyce, a mental health support worker, received the diagnosis thr
Grandaughter and gran BOTH diagnosed with aggressive breast cancer in same week
Daily Mirror / Posted 6 days ago
Brave Madison Joyce, a mental health support worker, received the diagnosis three months ago after noticing a lump in her left breast in May. Just days earlier, Madison’s gran-of-seven Maureen Stanway, 73, was also diagnosed with breast cancer which... Read more
15d
Daily Mirror
Breast cancer vaccine is 'huge discovery' that brings hope to thousands of womenA breast cancer vaccine could be on the way to tackle the most aggressive form
Breast cancer vaccine is 'huge discovery' that brings hope to thousands of women
Daily Mirror / Posted 15 days ago
A breast cancer vaccine could be on the way to tackle the most aggressive form of the disease. It gives fresh hope to ­thousands with the “triple negative” type – some 12% of the 50,000 patients diagnosed each year. Prof Graham Pockley from the... Read more
16d
walesonline
Mum of two with cancer to raise £69,000 to pay for treatment NHS don't giveA woman with a rare form of breast cancer is about to start life-prolonging tre
Mum of two with cancer to raise £69,000 to pay for treatment NHS don't give
walesonline / Posted 16 days ago
A woman with a rare form of breast cancer is about to start life-prolonging treatment after being forced to pay for it herself when she was turned down twice by the NHS in Wales. Mum-of-two Carolyn Davies, 47, from Cwmbran, was diagnosed with breast... Read more
25d
Reuters
Pfizer, Bristol revive cancer drugs that rev up immune systemThe Pfizer logo is seen at their world headquarters in New York April 28, 2014.
Pfizer, Bristol revive cancer drugs that rev up immune system
Reuters / Posted 25 days ago
The Pfizer logo is seen at their world headquarters in New York April 28, 2014. NEW YORK Some of the most heralded new cancer drugs fight the disease by removing brakes on the immune system. Now a few leading drugmakers are paying attention to a... Read more
2 related stories
25d
Channel NewsAsia
Pfizer, Bristol revive cancer drugs that rev up immune systemNEW YORK: Some of the most heralded new cancer drugs fight the disease by remov
Pfizer, Bristol revive cancer drugs that rev up immune system
Channel NewsAsia / Posted 25 days ago
NEW YORK: Some of the most heralded new cancer drugs fight the disease by removing brakes on the immune system. Now a few leading drugmakers are paying attention to a second, opposing force: medicines that accelerate the immune system's... Read more
2 related stories
28d
The Irish Times
Breast cancer: could it be treated with drugs alone? Oncologist Arnie Hill says research could see potentially fatal disease become
Breast cancer: could it be treated with drugs alone?
The Irish Times / Posted 28 days ago
Oncologist Arnie Hill says research could see potentially fatal disease become manageable condition Prof Arnie Hill, head of the medical school at the Royal College of Surgeons in Ireland (RCSI).... Read more
29d
The Irish Times
New ‘cocktails’ will test limits of cancer drug pricing Immunotherapy combinations to push prices to new highs as worldwide cancer dru
New ‘cocktails’ will test limits of cancer drug pricing
The Irish Times / Posted 29 days ago
Immunotherapy combinations to push prices to new highs as worldwide cancer drug spending hits $100bn in 2014 New cancer drug cocktails set to reach the market in the next few years will test... Read more
4 related stories
29d
Reuters UK Edition
New cocktails to test limits of cancer drug pricingLONDON New cancer drug cocktails set to reach the market in the next few years
New cocktails to test limits of cancer drug pricing
Reuters UK Edition / Posted 29 days ago
LONDON New cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing company executives to consider fresh market strategies. The growing reluctance of governments... Read more
4 related stories
29d
iol.co.za
The high cost of immunotherapyREUTERSDozens of new cancer combinations will be launched over the next few yea
The high cost of immunotherapy
iol.co.za / Posted 29 days ago
REUTERSDozens of new cancer combinations will be launched over the next few years, with ones for lung cancer, melanoma and other solid tumours taking off strongly after 2018, drug company pipelines suggest. London - New cancer drug cocktails set to... Read more
4 related stories
29d
Channel NewsAsia
New cocktails to test limits of cancer drug pricingLONDON: New cancer drug cocktails set to reach the market in the next few years
New cocktails to test limits of cancer drug pricing
Channel NewsAsia / Posted 29 days ago
LONDON: New cancer drug cocktails set to reach the market in the next few years will test the limits of premium pricing for life-saving medicines, forcing company executives to consider fresh market strategies. The growing reluctance of governments... Read more
4 related stories
m
Market Watch
Roche gets EU approval for cancer drug PerjetaZURICH--European regulators approved Roche Holding AG's Perjeta remedy for the
Roche gets EU approval for cancer drug Perjeta
Market Watch / Posted 1 months ago
ZURICH--European regulators approved Roche Holding AG's Perjeta remedy for the pre-surgery treatment of adult patients with breast cancer. Basel-based Roche Friday said the European Commission approved the use of its cancer drug Perjeta, in... Read more
m
The Times & The Sunday Times
Cancer survivor's new battlePietermaritzburg resident Judd-Stevens was diagnosed in October 2013 with breas
Cancer survivor's new battle
The Times & The Sunday Times / Posted 1 months ago
Pietermaritzburg resident Judd-Stevens was diagnosed in October 2013 with breast cancer - a disease that killed her mother at the age of 44. She had the tumour removed, battled through chemotherapy and radiation, and is now cancer-free. But she had... Read more

People in this news